BioLife Solutions Inc

Most Recent

  • uploads///dna _
    Company & Industry Overviews

    Audentes Therapeutics’ Promising Product Pipeline

    In this series, we’ll take a look at six stocks with a focus on gene therapy that have promising products in their pipelines.

    By Kenneth Smith
  • uploads///Biolife revenue trend
    Company & Industry Overviews

    BioLife Solutions: On a Strong Footing

    BioLife Solutions (BLFS) generated revenues of $5.18 million in the second quarter compared to $2.56 million in Q2 2017.

    By Kenneth Smith
  • uploads///dna strand _
    Company & Industry Overviews

    Why BioLife Solutions Stock Rose ~49% Last Week

    On July 6, BioLife Solutions (BLFS) stock closed at $17.02, ~508% higher than its 52-week low of $2.80 on July 7, 2017.

    By Daniel Collins
  • uploads///BLFS
    Company & Industry Overviews

    Analyzing BioLife Solutions’ Target Market Dynamics

    According to BioLife Solutions, the total biopreservation market is expected to reach $9.7 billion by 2024.

    By Kenneth Smith
  • uploads///isolated _
    Company & Industry Overviews

    What Analysts Think of BioLife Solutions Stock

    BioLife Solutions (BLFS) has risen from a low of $10.90 on June 28 to a high of $17.60 on July 3. BLFS closed at $16.70 on July 3.

    By Kenneth Smith
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.